Pharma & Biotech

IO Biotech finds itself at a pivotal moment. As CEO Mai-Britt Zocca addresses investors at the Evercore Healthcare Conference, the...

The battle for dominance in the lucrative weight-loss drug sector is heating up. In a bold strategic move, Eli Lilly...

The Danish pharmaceutical giant Novo Nordisk finds itself navigating a period of significant market turbulence. Investor sentiment, already battered by...

InnoCan Pharma is facing a severe market downturn. Trading opened this week with shares collapsing by over 14%, settling at...

December has opened with a jolt for BioNTech and its investors. A strategic pivot toward oncology and a critical acquisition...

Despite a steady dividend and positive clinical trial news, AbbVie's stock price has struggled to gain momentum. This creates a...

The competitive landscape for treating Stargardt disease has intensified following a significant clinical announcement. While Ocugen continues developing its novel...

Investor nerves are being tested as shares in Healwell AI exhibit extreme volatility, trading dangerously close to a pivotal support...

The shares of biotech firm Capricor Therapeutics have become a pure speculative instrument, with their fate entirely dependent on the...

The biotech sector often presents a fascinating dichotomy, and Axsome Therapeutics currently embodies it perfectly. The company is experiencing a...